Trial intelligence / Profile preview

Optimal Nerve Block Location for ACL Surgery

NCT03401450Phase 4Completed

Sponsor
NYU Langone Health
Start
Feb 2018
Primary completion
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of bupivacaine in postoperative pain, sponsored by NYU Langone Health. Started Feb 2018; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03401450.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03401450.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call